United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$397.49 USD
+14.72 (3.85%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $397.55 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Earnings News For UTHR
-
United Therapeutics Q3 Earnings & Sales Beat Estimates
-
United Therapeutics (UTHR) Q3 Earnings and Revenues Top Estimates
-
United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?
-
United Therapeutics (UTHR) Q2 Earnings Lag, Sales Top Estimates
-
United Therapeutics: Q2 Earnings Snapshot
-
United Therapeutics (UTHR) Misses Q2 Earnings Estimates
-
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
-
Why Is United Therapeutics (UTHR) Up 4.8% Since Last Earnings Report?
-
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
-
United Therapeutics: Q1 Earnings Snapshot
-
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
-
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
-
Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?
-
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
-
United Therapeutics: Q4 Earnings Snapshot
-
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
-
United Therapeutics (UTHR) Up 5.2% Since Last Earnings Report: Can It Continue?
-
United Therapeutics (UTHR) Q3 Earnings & Sales Beat Estimates
-
United Therapeutics (UTHR) Q3 Earnings and Revenues Top Estimates
-
United Therapeutics: Q3 Earnings Snapshot
-
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
-
Analysts Estimate United Therapeutics (UTHR) to Report a Decline in Earnings: What to Look Out for
-
United Therapeutics (UTHR) Q2 Earnings & Sales Beat Estimates
-
United Therapeutics (UTHR) Tops Q2 Earnings and Revenue Estimates
-
United Therapeutics: Q2 Earnings Snapshot